Lamzarin 60 mg prolonged-release tablets
- Licence status
- Withdrawn: 12/08/2022
- Active substances
- Gliclazide
- Dosage Form
- Prolonged-release tablet
- Licence number
- PA23176/004/002
- Licence holder
- Lexon Pharmaceuticals (Ireland) Limited
Product documents
Licence information
- ATC code
- A10BB09 gliclazide
- Legal supply status
- Product subject to prescription which may be renewed (B)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Marketed
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 05/04/2019